Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Avita Medical
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The patient requires treatment of a life-threatening wound requiring grafting.
Patient has inadequate available skin to harvest for conventional skin grafting.
The treating investigator has determined 1) that there is no suitable alternative therapy that would be adequate to meet the patient's medical need; and 2) the risk associated with use of the ReCell device is no greater than the probable risk from the disease or condition.
In the treating investigator's opinion and with consideration of the severity of the patient's health status, the patient has the potential to realize benefits from the application of the ReCell device.
Patient is hemodynamically stable.
The patient (or legal representative) is able to read and understand instructions and give informed consent.
You may not be if
The patient has active infection at the proposed ReCell treatment site.
The patient is unable to follow the protocol.
The patient has a known hypersensitivity to trypsin or Compound Sodium Lactate for Irrigation (Hartmann's) solution.
Clareo Health | Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases
